← Open Payments lookup

JACKSON LAIZURE: Open Payments

NPI 1437535846 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,825 in 212 payments from 22 companies in 2025. Trend: 2023 $2,131 · 2024 $3,080 · 2025 $3,825

Food & beverage: $3,715Education: $109
CompanyPaymentsAmount
ABBVIE INC.48$668
Takeda Pharmaceuticals U.S.A., Inc.23$509
Janssen Biotech, Inc.27$489
Madrigal Pharmaceuticals12$376
Gilead Sciences, Inc.15$254
Lilly USA, LLC9$213
GENZYME CORPORATION13$202
Ipsen Biopharmaceuticals, Inc12$167
Aimmune Therapeutics, Inc.7$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$155

Products named: TREMFYA, REZDIFFRA, ENTYVIO, DUPIXENT, OMVOH, RINVOQ, IQIRVO, CREON.

Industry payments across OK — which companies pay providers there.